Zavegepant Nasal Spray (Zavzpret) is a small-molecule, competitive antagonist of the calcitonin gene-related peptide (CGRP) receptor, which is a target for the treatment of migraine. CGRP is a neuropeptide that is found in high levels in the trigeminal nerve, which is believed to play a role in migraine pathogenesis. CGRP exerts its effects on the vasculature, … Read more
BEOVU Indications: Wet age-related macular degeneration Brand Name: Beovu Drug Name: Brolucizumab Date of FDA Approval: 8th Oct 2019 Manufacturer: Novartis Pharmaceuticals [Ref] BEOVU® (Brolucizumab-dbll) injection is a medication that has been recently approved by the FDA for the treatment of wet age-related macular degeneration (AMD). It is one of the new molecules that block … Read more
Darolutamide MOA is discussed in this article. It is a recently approved chemotherapeutic drug for the treatment of prostate cancer. Drug Name: Darolutamide MOA Brand Name: Nubeqa The prostate is a prevalent malignancy that commonly affects elderly males. Most prostate cancers are responsive to hormones. A therapeutic objective is to impede their proliferation by inhibiting … Read more
Brenzavvy (Bexagliflozin) is a medication used to manage type 2 diabetes by reducing blood sugar levels through the elimination of excess glucose in the urine. While Brenzavvy can be an effective treatment option for many people, it’s important to be aware of the side effects of this medication. Understanding these side effects can help you … Read more
Adcetris (Brentuximab Vedotin) is a medication used to treat certain types of cancer, including Hodgkin lymphoma and a type of non-Hodgkin lymphoma called systemic anaplastic large cell lymphoma. It is an antibody-drug conjugate that works by targeting cancer cells and delivering a toxin to destroy them. While Adcetris has been shown to be effective in … Read more
Trofinetide MOA (Mechanism of action): Trofinetide is a synthetic peptide that has been developed as a potential treatment for Rett syndrome, a rare neurodevelopmental disorder that affects mainly girls. The mechanism of action of Trofinetide (Trofinetide MOA) is not fully understood, but it is believed to involve several different pathways in the brain. One of … Read more
Novartis’ Afinitor (everolimus) was approved by the FDA on February 26, 2016, for the treatment of adult patients with unresectable, locally advanced or metastatic progressive, well-differentiated non-functional neuroendocrine tumors (NETs) originating from the gastrointestinal or lung areas. Afinitor, also known as everolimus, is a type of medication categorized as an mTOR inhibitor. It is available … Read more
Tremelimumab is marketed by name, Imjudo. It is a CTLA-4 inhibitor that has been approved for the treatment of unresectable HCC and non-small-cell carcinoma. What is CTLA-4? CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) is a protein receptor that is expressed on the surface of T-cells (a type of immune cell). It functions as a negative regulator … Read more
Irritable Bowel Syndrome (IBS) is the most common gastrointestinal disorder. Many over-the-counter treatment options are now available to ease the unpleasant symptoms of IBS. But it often gets confusing to choose the right medicine according to your IBS type. A gastrointestinal (GI) illness called irritable bowel syndrome (IBS) is characterized by recurring episodes of abdominal … Read more
Ozempic (Semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist that helps regulate blood sugar levels and reduce appetite, leading to weight loss. However, once you stop taking the medication, your appetite and blood sugar levels may return to pre-treatment levels, which could cause weight gain. It’s important to remember that weight loss and weight management … Read more